Effects of Valeriana officinalis and Ciprofloxacin on Kidney Histopathology in Rats Pyelonephritis by Pseudomonas aeruginosa

Main Article Content

Fatemeh Salahshoori Niaei
Akbar Farah Taj Navab


Introduction: Urinary tract infection (UTI) is a bacterial infection that affects the urinary tract. The bacterial infection of the upper urinary tract is called nephritis. The purpose of this study was to evaluate the antibacterial effect of Valeriana officinalis and Ciprofloxacin on kidney histopathology in rats with pyelonephritis by Pseudomonas.

Materials and Methods: In this study, 48 male Wistar rats were divided into six groups and each group had two replicates. The first group was considered a control and received 0.1 mg/ kg/day of saline daily for a month. The second group received a single injection of 0.5 McFarland of microbial suspension per kilogram of animal into the pelvis of the right kidney of the rats, resulting in pyelonephritis. The third group of rats received 0.9 mg/kg/day methanolic extract of Valeriana officinalis intraperitoneally for a month. The fourth group of rats received Ciprofloxacin intraperitoneally for a month at a dose of 0.6 mg/kg/day. Group five contained rats with pyelonephritis that received the antibiotic (Ciprofloxacin) at a dosage of 0.6 mg/kg/day. Group six with pyelonephritis received 0.9 mg/kg/day of Valeriana officinalis extract. The inflammation in the cortex, Pelvic, medulla, and tissue sections was studied at the end of the study.

Results: The rats that received Valeriana officinalis extract improved pelvic and medullary tissue, the site of Pseudomonas bacteria, and prevented the destruction of renal cortex tissue. The rats that received Ciprofloxacin had fewer medullary and tissue inflammations.

Conclusion: According to the results of this research, the extract not only improved the tissue of the pelvis and medulla, which is where Pseudomonas bacteria live, but it also inhibits the degradation of renal cortex tissue. It was proven to diminish medullary inflammation to some extent, but in rats, it exacerbated the loss of renal cortex tissue.

Article Details

How to Cite
Salahshoori Niaei, F., & Farah Taj Navab, A. (2022). Effects of Valeriana officinalis and Ciprofloxacin on Kidney Histopathology in Rats Pyelonephritis by Pseudomonas aeruginosa. Research in Biotechnology and Environmental Science, 1(1), 23–27. https://doi.org/10.58803/rbes.v1i1.5
Original Article


Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews microbiology. 2015; 13(5): 269-284. Doi: 10.1038/nrmicro3432

Roberts JA. Etiology and pathophysiology of pyelonephritis. American Journal of Kidney Diseases. 1991; 17(1): 1-9. Doi: 10.1016/S0272-6386(12)80242-3

Raszka Jr WV, Khan O. Pyelonephritis. Pediatrics in review. 2005;26(10):364-70. Doi: 10.1542/pir.26-10-364

Kucheria R, Dasgupta P, Sacks SH, Khan MS, Sheerin NS. Urinary tract infections: new insights into a common problem. Postgraduate Medical Journal. 2005;81:83-6. Doi: 10.1136/pgmj.2004.023036

Fluit AC, Schmitz FJ, Verhoef J. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. European Journal of Clinical Microbiology and Infectious Diseases. 2001;20(3):188-91. Doi: 10.1007/s100960100455

Mittal R, Aggarwal S, Sharma S, Chhibber S, Harjai K. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview. Journal of infection and public health. 2009; 2(3):101-11. Doi: 10.1016/j.jiph.2009.08.003

Pobiega M, Maciag J, Pomorska-Wesolowska M, Chmielarczyk A, Romaniszyn D, Ziolkowski G, et al. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: Virulence factors and antibiotic resistance. Journal of Pediatric Urology. 2016;12(1):36-e1. Doi: 10.1016/j.jpurol.2015.05.034

Nandhini S, Narayanan KB, Ilango K. Valeriana officinalis: A review of its traditional uses, phytochemistry and pharmacology. Asian Journal of Pharmaceutical and Clinical Research. 2018;11(1):36-41. Doi: 10.22159/ajpcr.2018.v11i1.22588

Khodadustan E, Kazemeini H, Kheirollahi AR, Mahmoodnia L, Hatamikia M, Hasanvand A. Medicinal plants for kidney pain: An ethnobotanical study on Shahrekord city, West of Iran. Plant Science Today. 2019.

Nagara ZZ, Saour KY. Phytochemical and pharmacological study of Valepotriates in Valeriana officinalis LF Valerianeceae cultivated in Iraq. Iraqi Journal of Pharmaceutical Sciences. 2015;24(1):1-0. Doi: 10.31351/vol24iss1pp1-10

Institute of Laboratory Animal Resources (US). Committee on Care, Use of Laboratory Animals. Guide for the care and use of laboratory animals. US Department of Health and Human Services, Public Health Service, National Institutes of Health; 1986.

de Oliveria DM, Barreto G, De Andrade DV, Saraceno E, Aon-Bertolino L, Capani F, et al. Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochemical Research. 2009;34(2):215-20. Doi: 10.1007/s11064-008-9749-y

Miller T, Phillips S. Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy. Kidney international. 1981;19(5):654-62. Doi: 10.1038/ki.1981.65

Eadon MT, Schwantes-An TH, Phillips CL, Roberts AR, Greene CV, Hallab A, et al. Kidney histopathology and prediction of kidney failure: a retrospective cohort study. American Journal of Kidney Diseases. 2020;76(3):350-60. Doi: 10.1053/j.ajkd.2019.12.014

Eftekhari Z. Antimicrobial properties of medicinal plants; The new therapeutic aspect of Valeriana officinalis. Plant Biotechnology Persa. 2020 10;2(1):59-60.

Chen HW, Wei BJ, He, XH, Liu Y, Wang J. Chemical components and cardiovascular activities of Valeriana spp. Evidence-Based Complementary and Alternative Medicine. 2015;2015. Doi: 10.1155/2015/947619

Sanchez M, Burgos EG, Iglesias I, Gomez-Serranillos MP. Updating

the biological interest of Valeriana officinalis. Mediterr Bot. 2021;42:e70280. Doi: 10.5209/mbot.70280

Rondón M, Velasco J, Rojas J, Gámez L, León G, Entralgo E, Morales A. Antimicrobial activity of four Valeriana (Caprifoliaceae) species endemic to the Venezuelan Andes. Revista de Biología Tropical. 2018;66(3):1282-9. Doi: 10.15517/rbt.v66i3.30699

Wang J, Zhao J, Liu H, Zhou L, Liu Z, Wang J, et al. Chemical analysis and biological activity of the essential oils of two valerianaceous species from China: Nardostachys chinensis and Valeriana officinalis. Molecules. 2010;15(9):6411-22. Doi: 10.3390/molecules15096411

Tsuchimori N, Hayashi R, Shino A, Yamazaki T, Okonogi K. Enterococcus faecalis aggravates pyelonephritis caused by Pseudomonas aeruginosa in experimental ascending mixed urinary tract infection in mice. Infection and immunity. 1994;62(10):4534-41. Doi: 10.1128/iai.62.10.4534-4541.1994

Mittal R, Sharma S, Chhibber S, Harjai K. Evaluation of tumour necrosis factor-alpha and interleukin-1beta in an experimental pyelonephritis model induced with planktonic and biofilms cells of Pseudomonas aeruginosa. Canadian Journal of Infectious Diseases and Medical Microbiology. 2009;20(3):e35-42. Doi: 10.1155/2009/810791

Lu Q, Yu J, Bao L, Ran T, Zhong H. Effects of combined treatment with ambroxol and Ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model. Chemotherapy. 2013;59(1):51-6. Doi: 10.1159/000351107